Description: Mera Pharmaceuticals, Inc. primarily develops and commercializes natural products derived principally from microalgae using its patented photobioreactor technology. It produces various substances and bioactive compounds that have applications in a range of commercial areas, including human nutrition, pharmaceuticals, and other commodities, such as bio-diesel. The company's products include ASTAFACTOR, a nutraceutical and source of natural astaxanthin; SALMON ESSENTIALS, a combination of astaxanthin and omega-3 fatty acids; and KONA SEA SALT. It markets its products to mass retail outlets in Hawaii through distribution arrangements with companies. The company also operates a chain of professional martial arts studios. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Pembroke Pines, Florida.
Home Page: www.merapharma.com
8275 S. Easter Avenue
Las Vegas,
NV
89123
United States
Phone:
604 500 4157
Officers
| Name | Title |
|---|---|
| Mr. Benny Doro | CEO, Interim Director, Pres & Sec. |
| Mr. Lawrence Harris Wolfe | Chief Financial Officer, VP of Fin. and Director |
| Ms. Melanie K. Kelekolio | Gen. Mang. of The Operations & Production Facility and VP |
| Ms. Joyce Markley | Sec. and Director |
| Mr. Rafi Markarians | Treasurer & Director |
| Mr. Russell M. Yamamoto | Director of Site Devel. and Planning |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 3.6201 |
| IPO Date: | |
| Fiscal Year End: | October |
| Full Time Employees: | 0 |